Emulate Stock

Emulate, Inc., a leading provider of next-generation in vitro models, today announced that it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2023.

Of the drugs that pass animal tests, more than 90% later fail in human clinical trials. But better technology could begin to replace the use of some animals—and make drug development cheaper and more effective.

For nearly a century, the drug trial process has remained the same. Researchers use animal testing before advancing drugs to human clinical trials. But this method is imperfect.